Shares of Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) climbed 5.4% mid-day Tuesday as remarks by RFK Jr, who clarified his stance as not being anti-vaccine or anti-industry, appeared to bolster investor ...

Another company that scored an approval for its mRNA COVID-19 vaccine, Moderna, is also progressing its pipeline of candidates against cancer. The bulk of its targets within cancer utilise its ...

Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial.

On one of the final days of the Biden Administration, the US Department of Health and Human Services (HHS) announced $590 million in support for Moderna to speed the development of mRNA vaccines ...

Moderna's MRNA +3.99% Get Free Report short percent of float has risen 13.6% since its last report. The company recently ...

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%. Elsewhere ...